Published in J Clin Virol on April 01, 2011
Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasis-associated bladder malignancies. Proc Natl Acad Sci U S A (2005) 1.74
Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women. Int J Cancer (2005) 1.51
Detection and quantitation of human papillomavirus DNA in the plasma of patients with cervical carcinoma. Cancer Epidemiol Biomarkers Prev (2002) 1.09
Human papillomavirus DNA in plasma of patients with cervical cancer. BMC Cancer (2001) 0.97
HPV DNA in plasma of patients with cervical carcinoma. J Clin Virol (2004) 0.92
Detection and quantitation of human papillomavirus type 16, 18 and 52 DNA in the peripheral blood of cervical cancer patients. Gynecol Oncol (2005) 0.91
Development and evaluation of a PCR and mass spectroscopy (PCR-MS)-based method for quantitative, type-specific detection of human papillomavirus. J Virol Methods (2009) 0.90
Detection of HPV 16 and HPV 18 DNA in the blood of patients with cervical cancer. J Med Virol (2005) 0.90
Low incidence of HPV DNA in sera of pretreatment cervical cancer patients. Gynecol Oncol (2001) 0.90
Detection and typing of minimal human papillomavirus DNA in plasma. Int J Gynaecol Obstet (2007) 0.90
Human papillomavirus DNA in sera of cervical cancer patients as tumor marker. Cancer Lett (2003) 0.85
Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2007) 13.20
Prevalence of HPV infection among females in the United States. JAMA (2007) 10.55
Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis (2013) 6.04
Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res (2003) 4.93
Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2014) 4.50
Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas. Arch Intern Med (2003) 4.46
Dose escalation of a curcuminoid formulation. BMC Complement Altern Med (2006) 3.59
Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis (2002) 3.42
Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005. Ann Intern Med (2008) 2.98
Chronic fatigue syndrome--a clinically empirical approach to its definition and study. BMC Med (2005) 2.97
Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. J Infect Dis (2011) 2.88
Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep (2015) 2.73
Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004. J Infect Dis (2009) 2.43
Differential regulation of noxa in normal melanocytes and melanoma cells by proteasome inhibition: therapeutic implications. Cancer Res (2005) 2.37
Recruitment of minority and underserved populations in the United States: the Centers for Population Health and Health Disparities experience. Contemp Clin Trials (2008) 2.29
Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. Cancer Epidemiol Biomarkers Prev (2008) 1.99
Psychometric properties of the CDC Symptom Inventory for assessment of chronic fatigue syndrome. Popul Health Metr (2005) 1.94
Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev (2008) 1.85
Identification and validation of the mitochondrial F1F0-ATPase as the molecular target of the immunomodulatory benzodiazepine Bz-423. Chem Biol (2005) 1.81
A population-based study of the clinical course of chronic fatigue syndrome. Health Qual Life Outcomes (2003) 1.80
The effect of correct and consistent condom use on chlamydial and gonococcal infection among urban adolescents. Arch Pediatr Adolesc Med (2005) 1.78
Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci U S A (2005) 1.77
Simultaneous amplification and identification of 25 human papillomavirus types with Templex technology. J Clin Microbiol (2006) 1.75
Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents. Am J Epidemiol (2005) 1.67
Microsatellite instability and DNA mismatch repair protein deficiency in Lynch syndrome colorectal polyps. Cancer Prev Res (Phila) (2012) 1.65
Efficient DNA extraction for HPV genotyping in formalin-fixed, paraffin-embedded tissues. J Mol Diagn (2011) 1.64
Individual and geographic disparities in human papillomavirus types 16/18 in high-grade cervical lesions: Associations with race, ethnicity, and poverty. Cancer (2013) 1.64
Familial risk for common diseases in primary care: the Family Healthware Impact Trial. Am J Prev Med (2009) 1.62
Manipulating the bioenergetics of alloreactive T cells causes their selective apoptosis and arrests graft-versus-host disease. Sci Transl Med (2011) 1.61
Cervical cancer incidence in a prevaccine era in the United States, 1998-2002. Obstet Gynecol (2007) 1.60
Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia. Vaccine (2009) 1.53
Epidemiologic and viral factors associated with cervical neoplasia in HPV-16-positive women. Int J Cancer (2005) 1.51
Effects of ginger supplementation on cell-cycle biomarkers in the normal-appearing colonic mucosa of patients at increased risk for colorectal cancer: results from a pilot, randomized, and controlled trial. Cancer Prev Res (Phila) (2013) 1.49
Overcoming challenges in designing and implementing a phase II randomized controlled trial using a presurgical model to test a dietary intervention in prostate cancer. Clin Trials (2008) 1.48
Chromoendoscopy detects more adenomas than colonoscopy using intensive inspection without dye spraying. Cancer Prev Res (Phila) (2008) 1.47
Pharmacokinetics of 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol and conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev (2008) 1.45
UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line. Head Neck (2011) 1.45
Recruitment and retention of economically underserved women to a cervical cancer prevention trial. Appl Nurs Res (2004) 1.41
Epidemiology of human papillomavirus infection and abnormal cytologic test results in an urban adolescent population. J Infect Dis (2003) 1.39
Clinical utility of family history for cancer screening and referral in primary care: a report from the Family Healthware Impact Trial. Genet Med (2011) 1.38
Early adverse experience and risk for chronic fatigue syndrome: results from a population-based study. Arch Gen Psychiatry (2006) 1.31
Pancreatic cancer serum detection using a lectin/glyco-antibody array method. J Proteome Res (2009) 1.30
Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot. J Proteome Res (2008) 1.29
Adults' knowledge and behaviors related to human papillomavirus infection. J Am Board Fam Pract (2004) 1.27
Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction. J Low Genit Tract Dis (2012) 1.26
Comparison of risk perceptions and beliefs across common chronic diseases. Prev Med (2008) 1.24
Post-licensure monitoring of HPV vaccine in the United States. Vaccine (2010) 1.24
HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans. Head Neck (2010) 1.23
Human papillomavirus infection and cytologic abnormalities of the anus and cervix among HIV-infected women in the study to understand the natural history of HIV/AIDS in the era of effective therapy (the SUN study). Sex Transm Dis (2011) 1.21
Utility of the blood for gene expression profiling and biomarker discovery in chronic fatigue syndrome. Dis Markers (2002) 1.20
A real-time PCR assay for HPV52 detection and viral load quantification. Clin Lab (2012) 1.18
DNA and RNA references for qRT-PCR assays in exfoliated cervical cells. J Mol Diagn (2006) 1.15
Mass spectrometric assay for analysis of haptoglobin fucosylation in pancreatic cancer. J Proteome Res (2011) 1.14
Primary and secondary prevention of cervical cancer--opportunities and challenges. J Natl Cancer Inst (2009) 1.13
Dysfunctional apoptosome activation in ovarian cancer: implications for chemoresistance. Cancer Res (2002) 1.13
Effector T cells require fatty acid metabolism during murine graft-versus-host disease. Blood (2013) 1.13
Population impact of HPV vaccines: summary of early evidence. J Adolesc Health (2013) 1.12
Family history and perceptions about risk and prevention for chronic diseases in primary care: a report from the family healthware impact trial. Genet Med (2010) 1.12
Human papillomavirus and molecular considerations for cancer risk. Cancer (2008) 1.12
Factor analysis of symptoms among subjects with unexplained chronic fatigue: what can we learn about chronic fatigue syndrome? J Psychosom Res (2004) 1.12
Human papillomavirus genotypes in high-grade cervical lesions in the United States. J Infect Dis (2012) 1.12
Human papillomavirus (HPV) 6, 11, 16, and 18 prevalence among females in the United States--National Health And Nutrition Examination Survey, 2003-2006: opportunity to measure HPV vaccine impact? J Infect Dis (2011) 1.11
Missed adenomas during colonoscopic surveillance in individuals with Lynch Syndrome (hereditary nonpolyposis colorectal cancer). Cancer Prev Res (Phila) (2008) 1.11
HDAC6 deacetylates Ku70 and regulates Ku70-Bax binding in neuroblastoma. Neoplasia (2011) 1.11
Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome. J Transl Med (2003) 1.10
Resveratrol inhibits glucose metabolism in human ovarian cancer cells. Gynecol Oncol (2007) 1.09
Serum metabolomic analysis of pancreatic cancer--letter. Cancer Epidemiol Biomarkers Prev (2013) 1.07
Alterations in diurnal salivary cortisol rhythm in a population-based sample of cases with chronic fatigue syndrome. Psychosom Med (2008) 1.06
What is lacking in current decision aids on cancer screening? CA Cancer J Clin (2013) 1.06
Sensitive and specific peak detection for SELDI-TOF mass spectrometry using a wavelet/neural-network based approach. PLoS One (2012) 1.06
Seroprevalence of human papillomavirus type 16 in children. J Infect Dis (2005) 1.06
CREB-binding protein is a mediator of neuroblastoma cell death induced by the histone deacetylase inhibitor trichostatin A. Neoplasia (2007) 1.05
Sleep characteristics of persons with chronic fatigue syndrome and non-fatigued controls: results from a population-based study. BMC Neurol (2006) 1.05
Assessing the relationship between HIV infection and cervical cancer in Côte d'Ivoire: a case-control study. BMC Infect Dis (2010) 1.05
Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting. Support Care Cancer (2008) 1.05
CDC grand rounds: Reducing the burden of HPV-associated cancer and disease. MMWR Morb Mortal Wkly Rep (2014) 1.05
Benzodiazepine-induced superoxide signals B cell apoptosis: mechanistic insight and potential therapeutic utility. J Clin Invest (2002) 1.05
Identifying illness parameters in fatiguing syndromes using classical projection methods. Pharmacogenomics (2006) 1.05
Glycoprotein biomarker panel for pancreatic cancer discovered by quantitative proteomics analysis. J Proteome Res (2014) 1.04
Type-specific reproducibility of the Roche linear array HPV genotyping test. J Clin Virol (2008) 1.04
Human papillomavirus prevalence in oropharyngeal cancer before vaccine introduction, United States. Emerg Infect Dis (2014) 1.04
Molecular quality of exfoliated cervical cells: implications for molecular epidemiology and biomarker discovery. Cancer Epidemiol Biomarkers Prev (2004) 1.04
Elevated expression of the oncogene c-fms and its ligand, the macrophage colony-stimulating factor-1, in cervical cancer and the role of transforming growth factor-beta1 in inducing c-fms expression. Cancer Res (2007) 1.04
Impact of human papillomavirus (HPV) vaccination on HPV 16/18-related prevalence in precancerous cervical lesions. Vaccine (2012) 1.03
Gene expression correlates of unexplained fatigue. Pharmacogenomics (2006) 1.03
Evaluation of the rapid BioStar optical immunoassay for detection of Chlamydia trachomatis in adolescent women. J Clin Microbiol (2008) 1.03
Quantitation of site-specific HPV 16 DNA methylation by pyrosequencing. J Virol Methods (2006) 1.02
Human papillomavirus prevalence in invasive anal cancers in the United States before vaccine introduction. J Low Genit Tract Dis (2013) 1.02
National registry for juvenile-onset recurrent respiratory papillomatosis. Arch Otolaryngol Head Neck Surg (2003) 1.02
Performance of commercial reverse line blot assays for human papillomavirus genotyping. J Clin Microbiol (2012) 1.01
Human papillomavirus type 16 E2 and E6/E7 variants. Gynecol Oncol (2005) 1.00
Prevalence of cervical and oral human papillomavirus infections among US women. J Infect Dis (2013) 0.99
Biomarkers of Psychological Stress in Health Disparities Research. Open Biomark J (2008) 0.99
Regional distribution of fatiguing illnesses in the United States: a pilot study. Popul Health Metr (2004) 0.98